Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.

  1. Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.
    Chennamadhavuni, D.; Saavedra-Avila, N. A.; Carreño, L. J.; Guberman-Pfeffer, M. J.; Arora, P.; Yongqing, T.; Koay, H.; Godfrey, D.; Keshipeddy, S.; Richardson, S. K.; Sundararaj, S.; Lo, J. H.; Wen, X.; Gascón, J. A.; Yuan, W.; Rossjohn, J.; Le Nours, J.; Porcelli, S. A.; Amy R Howell Cell Chem. Biol. (2018) 25, 1-14. [DOI]